Articles

Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes

Heinrich-Heine-Universität, Düsseldorf, Germany
Policlinico S. Orsola-Malpighi, Bologna, Italy
IRCCS Policlinico S. Matteo, Pavia, Italy
Service d’hématologie Clinique, Hôpital Avicenne/Université Paris, Bobigny, France
Medizinische Hochschule Hannover, Hannover, Germany
CHU Brabois, Vandoeuvre Cédex, France
Stadtspital Triemli, Zurich, Switzerland
Mater Hospital, Brisbane, Australia
Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Paris, France
Novartis Pharmaceuticals, East Hanover, NJ, USA
Novartis Pharmaceuticals, East Hanover, NJ, USA
Novartis Pharma AG, Basel, Switzerland
Hôpital Saint-Vincent de Paul, Lille, France
Vol. 97 No. 9 (2012): September, 2012 https://doi.org/10.3324/haematol.2011.048546